247 related articles for article (PubMed ID: 35198466)
1. RegiSCAR DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) Validation Scoring System and Japanese Consensus Group Criteria for Atypical Drug-Induced Hypersensitivity Syndrome (DiHS): A Comparative Analysis.
Sasidharanpillai S; Ajithkumar K; Jishna P; Khader A; Anagha KV; Binitha MP; Chathoth AT
Indian Dermatol Online J; 2022; 13(1):40-45. PubMed ID: 35198466
[TBL] [Abstract][Full Text] [Related]
2. Case report: Sulfasalazine-induced hypersensitivity.
Kuchinskaya EM; Chikova IA; Kostik MM
Front Med (Lausanne); 2023; 10():1140339. PubMed ID: 37293296
[TBL] [Abstract][Full Text] [Related]
3. Comparison of diagnostic criteria and determination of prognostic factors for drug reaction with eosinophilia and systemic symptoms syndrome.
Kim DH; Koh YI
Allergy Asthma Immunol Res; 2014 May; 6(3):216-21. PubMed ID: 24843796
[TBL] [Abstract][Full Text] [Related]
4. Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome: clinical features of 27 patients.
Avancini J; Maragno L; Santi CG; Criado PR
Clin Exp Dermatol; 2015 Dec; 40(8):851-9. PubMed ID: 26271788
[TBL] [Abstract][Full Text] [Related]
5. Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR).
Kano Y; Tohyama M; Aihara M; Matsukura S; Watanabe H; Sueki H; Iijima M; Morita E; Niihara H; Asada H; Kabashima K; Azukizawa H; Hashizume H; Nagao K; Takahashi H; Abe R; Sotozono C; Kurosawa M; Aoyama Y; Chu CY; Chung WH; Shiohara T
J Dermatol; 2015 Mar; 42(3):276-82. PubMed ID: 25623158
[TBL] [Abstract][Full Text] [Related]
6. A Case of Vancomycin-Induced Drug Reaction with Eosinophilia, Systemic Symptoms and Multiorgan Involvement Proven Using Lymphocyte Transformation Test.
Chung KB; Hwang JH; Kim D
Ann Dermatol; 2023 Apr; 35(2):140-145. PubMed ID: 37041708
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to lamotrigine differs from that due to other drugs.
Tashiro Y; Azukizawa H; Asada H; Niihara H; Morita E; Yamauchi T; Mizukawa Y; Kusakabe Y; Numazawa S; Izumi M; Sueki H; Watanabe H
J Dermatol; 2019 Mar; 46(3):226-233. PubMed ID: 30663091
[TBL] [Abstract][Full Text] [Related]
8. Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS).
Miyagawa F; Asada H
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670052
[TBL] [Abstract][Full Text] [Related]
9. Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis.
Hama N; Abe R; Gibson A; Phillips EJ
J Allergy Clin Immunol Pract; 2022 May; 10(5):1155-1167.e5. PubMed ID: 35176506
[TBL] [Abstract][Full Text] [Related]
10. Drug Reaction With Eosinophilia and Systemic Symptoms: A Systematic Review.
Awad A; Goh MS; Trubiano JA
J Allergy Clin Immunol Pract; 2023 Jun; 11(6):1856-1868. PubMed ID: 36893848
[TBL] [Abstract][Full Text] [Related]
11. Clinical features of drug-induced hypersensitivity syndrome to BRAF inhibitors with and without previous immune checkpoint inhibition: a review.
Maloney NJ; Rana J; Yang JJ; Zaba LC; Kwong BY
Support Care Cancer; 2022 Mar; 30(3):2839-2851. PubMed ID: 34546454
[TBL] [Abstract][Full Text] [Related]
12. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) with Teicoplanin: A Case Report.
Ebrahimpour S; Mohammadi M; Gholami K
Drug Saf Case Rep; 2017 Dec; 4(1):1. PubMed ID: 28000142
[TBL] [Abstract][Full Text] [Related]
13. DRESS/DiHS syndrome induced by Propylthiouracil: a case report.
Shen Q; Wang Q; Zang H; Yu L; Cong X; Chen X; Chen L
BMC Endocr Disord; 2023 Jan; 23(1):22. PubMed ID: 36691013
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review.
Sharifzadeh S; Mohammadpour AH; Tavanaee A; Elyasi S
Eur J Clin Pharmacol; 2021 Mar; 77(3):275-289. PubMed ID: 33025080
[TBL] [Abstract][Full Text] [Related]
15. Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases.
de Filippis R; Kane JM; Kuzo N; Spina E; De Sarro G; de Leon J; De Fazio P; Schoretsanitis G
Eur Neuropsychopharmacol; 2022 Jul; 60():25-37. PubMed ID: 35635994
[TBL] [Abstract][Full Text] [Related]
16. Serum Soluble OX40 as a Diagnostic and Prognostic Biomarker for Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms.
Mitsui Y; Shinkuma S; Nakamura-Nishimura Y; Ommori R; Ogawa K; Miyagawa F; Mori Y; Tohyama M; Asada H
J Allergy Clin Immunol Pract; 2022 Feb; 10(2):558-565.e4. PubMed ID: 34757063
[TBL] [Abstract][Full Text] [Related]
17. An investigation into the avoidability of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
Danjuma MI; Naseralallah LMA; AbouJabal B; Mohamed MF; Abubeker IY; Jabbar LA; Elzouki A
Sci Rep; 2021 Sep; 11(1):17887. PubMed ID: 34504198
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand.
Hiransuthikul A; Rattananupong T; Klaewsongkram J; Rerknimitr P; Pongprutthipan M; Ruxrungtham K
Allergol Int; 2016 Oct; 65(4):432-438. PubMed ID: 27134114
[TBL] [Abstract][Full Text] [Related]
19. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study.
Kardaun SH; Sekula P; Valeyrie-Allanore L; Liss Y; Chu CY; Creamer D; Sidoroff A; Naldi L; Mockenhaupt M; Roujeau JC;
Br J Dermatol; 2013 Nov; 169(5):1071-80. PubMed ID: 23855313
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal analysis of antibody profiles against plakins in severe drug eruptions: emphasis on correlation with tissue damage in drug-induced hypersensitivity syndrome and drug reaction with eosinophilia and systemic symptoms.
Takehara A; Aoyama Y; Kurosawa M; Shirafuji Y; Umemura H; Kamiya K; Ushigome Y; Kano Y; Shiohara T; Iwatsuki K
Br J Dermatol; 2016 Nov; 175(5):944-952. PubMed ID: 27087170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
